Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | llasorsa |
|---|---|
| Group name | EquipeMY |
| Item Type | Attachment |
| Title | Version soumise |
| URL | https://hal.archives-ouvertes.fr/hal-03047079/file/2020%20Roch%20et%20al.%2C%20Cachexia.pdf |
| Accessed | 2022/09/29 - 17:17:07 |
| Date Added | 2022/09/29 - 15:17:07 |
| Date Modified | 2022/09/29 - 15:17:07 |
| Parent item | Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de